Work
FDA financial report to Congress on PDUFA, FY 2025
The FDA's annual report on the prescription drug user fees, with five-year tables of costs and funding sources.
- Dates
- 2025
Connections 1
author
- U.S. Food and Drug Administration Primary record 1
Timeline 1 date
- 2025 FDA financial report to Congress on PDUFA, FY 2025
Proof 1 source
-
Financial Report to Congress: Prescription Drug User Fee Amendments, FY 2025, U.S. Food and Drug Administration.
Primary record
Historical Prescription Drug Activity Obligations by Funding Source
74% 76% 74% 78% 77%
PDUFA fees may be expended only for costs to support the “process for the review of human drug applications,”
The spending trigger was $287,573,564 for FY 2025, less than the $398,956,452 for non-user fee appropriations obligated for FY 2025, meaning the trigger was met.
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.